Richard L. Raymond

Array ( [id] => 1056487 [patent_doc_number] => 06855711 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-02-15 [patent_title] => 'Pharmaceutical compositions comprising iron chelators for the treatment of neurodegenerative disorders and some novel iron chelators' [patent_app_type] => utility [patent_app_number] => 10/009300 [patent_app_country] => US [patent_app_date] => 2000-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10812 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/855/06855711.pdf [firstpage_image] =>[orig_patent_app_number] => 10009300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1578582 [patent_doc_number] => 06448239 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-10 [patent_title] => 'Peroxynitrite decomposition catalysts and methods of use thereof' [patent_app_type] => B1 [patent_app_number] => 09/587382 [patent_app_country] => US [patent_app_date] => 2000-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9311 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/448/06448239.pdf [firstpage_image] =>[orig_patent_app_number] => 09587382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1450558 [patent_doc_number] => 06455532 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-24 [patent_title] => 'Pyrazinone thrombin inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/585112 [patent_app_country] => US [patent_app_date] => 2000-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16413 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1977 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/455/06455532.pdf [firstpage_image] =>[orig_patent_app_number] => 09585112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1436151 [patent_doc_number] => 06355795 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-12 [patent_title] => 'Triphendioxazine compounds' [patent_app_type] => B1 [patent_app_number] => 09/583973 [patent_app_country] => US [patent_app_date] => 2000-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4288 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/355/06355795.pdf [firstpage_image] =>[orig_patent_app_number] => 09583973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1601008 [patent_doc_number] => 06476021 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-05 [patent_title] => 'Compounds having cGMP-PDE inhibitory effect' [patent_app_type] => B1 [patent_app_number] => 09/580657 [patent_app_country] => US [patent_app_date] => 2000-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 59573 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/476/06476021.pdf [firstpage_image] =>[orig_patent_app_number] => 09580657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4406922 [patent_doc_number] => 06232309 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-15 [patent_title] => 'Insecticidal heterocyclic compounds' [patent_app_type] => 1 [patent_app_number] => 9/575240 [patent_app_country] => US [patent_app_date] => 2000-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4172 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/232/06232309.pdf [firstpage_image] =>[orig_patent_app_number] => 575240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1587034 [patent_doc_number] => 06359130 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'Bridged indenopyrrolocarbazoles' [patent_app_type] => B1 [patent_app_number] => 09/572160 [patent_app_country] => US [patent_app_date] => 2000-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19088 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1030 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/359/06359130.pdf [firstpage_image] =>[orig_patent_app_number] => 09572160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409134 [patent_doc_number] => 06232489 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-15 [patent_title] => 'Preparation of arthropodicidal oxadiazines' [patent_app_type] => 1 [patent_app_number] => 9/567639 [patent_app_country] => US [patent_app_date] => 2000-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7094 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/232/06232489.pdf [firstpage_image] =>[orig_patent_app_number] => 567639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1475040 [patent_doc_number] => 06387908 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Epoxysuccinamide derivatives' [patent_app_type] => B1 [patent_app_number] => 09/508026 [patent_app_country] => US [patent_app_date] => 2000-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15409 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387908.pdf [firstpage_image] =>[orig_patent_app_number] => 09508026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7615216 [patent_doc_number] => 06897308 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-24 [patent_title] => 'Process for the preparation of anti-psychotic 3-[2-[-4-(6-fluoro-1,2-benziosoxazol-3-yl)-1-piperidinyl] ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one' [patent_app_type] => utility [patent_app_number] => 10/257981 [patent_app_country] => US [patent_app_date] => 2000-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2922 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/897/06897308.pdf [firstpage_image] =>[orig_patent_app_number] => 10257981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4330872 [patent_doc_number] => 06313119 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-06 [patent_title] => 'Sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion' [patent_app_type] => 1 [patent_app_number] => 9/564988 [patent_app_country] => US [patent_app_date] => 2000-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19700 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 681 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/313/06313119.pdf [firstpage_image] =>[orig_patent_app_number] => 564988 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1504791 [patent_doc_number] => 06465644 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-15 [patent_title] => 'Sulfonated 8,9 benzophenoxazine dyes and the use of their labelled conjugates' [patent_app_type] => B1 [patent_app_number] => 09/564417 [patent_app_country] => US [patent_app_date] => 2000-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13733 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 451 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/465/06465644.pdf [firstpage_image] =>[orig_patent_app_number] => 09564417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4330859 [patent_doc_number] => 06320049 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-20 [patent_title] => 'Alpha 1a adrenergic receptor antagonists' [patent_app_type] => 1 [patent_app_number] => 9/563203 [patent_app_country] => US [patent_app_date] => 2000-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20045 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 484 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/320/06320049.pdf [firstpage_image] =>[orig_patent_app_number] => 563203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1040661 [patent_doc_number] => 06869959 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-03-22 [patent_title] => 'Heterocyclic carboxylic acid derivatives' [patent_app_type] => utility [patent_app_number] => 09/926407 [patent_app_country] => US [patent_app_date] => 2000-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10612 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/869/06869959.pdf [firstpage_image] =>[orig_patent_app_number] => 09926407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4312158 [patent_doc_number] => 06316448 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Pyrazolo[3,4-d][1,2,3] troazines having anticonvulsant activity and process for their preparation' [patent_app_type] => 1 [patent_app_number] => 9/575479 [patent_app_country] => US [patent_app_date] => 2000-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1489 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316448.pdf [firstpage_image] =>[orig_patent_app_number] => 575479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1545853 [patent_doc_number] => 06444672 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-03 [patent_title] => 'Heterocyclic derivatives and their use as antithrombotic agents' [patent_app_type] => B1 [patent_app_number] => 09/550954 [patent_app_country] => US [patent_app_date] => 2000-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58362 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 470 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/444/06444672.pdf [firstpage_image] =>[orig_patent_app_number] => 09550954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1420563 [patent_doc_number] => 06506760 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-14 [patent_title] => 'Substituted hydrazinyl heteroaromatic inhibitors of thrombin' [patent_app_type] => B1 [patent_app_number] => 09/550090 [patent_app_country] => US [patent_app_date] => 2000-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 18 [patent_no_of_words] => 37414 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 355 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/506/06506760.pdf [firstpage_image] =>[orig_patent_app_number] => 09550090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1166630 [patent_doc_number] => 06756386 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-29 [patent_title] => 'Azaring-ether derivatives and their use as nicotinic ACh receptor modulators' [patent_app_type] => B1 [patent_app_number] => 09/550379 [patent_app_country] => US [patent_app_date] => 2000-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7935 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/756/06756386.pdf [firstpage_image] =>[orig_patent_app_number] => 09550379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1420583 [patent_doc_number] => 06506761 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-14 [patent_title] => 'Substituted hydrazinyl heteroaromatic inhibitors of thrombin' [patent_app_type] => B1 [patent_app_number] => 09/550091 [patent_app_country] => US [patent_app_date] => 2000-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 20 [patent_no_of_words] => 37914 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 242 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/506/06506761.pdf [firstpage_image] =>[orig_patent_app_number] => 09550091 [rel_patent_id] =>[rel_patent_doc_number] =>)